Ligand Pharmaceuticals (LGND) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 40.09% |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn | -44.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.83% |
| Dec 31, 2025 | 27.91% |
| Sep 30, 2025 | 17.54% |
| Jun 30, 2025 | -28.19% |
| Mar 31, 2025 | -159.38% |
| Dec 31, 2024 | -48.77% |
| Sep 30, 2024 | 6.23% |
| Jun 30, 2024 | -53.38% |
| Mar 31, 2024 | 197.03% |
| Dec 31, 2023 | -109.22% |
| Sep 30, 2023 | 1,626.88% |
| Jun 30, 2023 | -100.91% |
| Mar 31, 2023 | 411.17% |
| Dec 31, 2022 | -317.32% |
| Sep 30, 2022 | 305.77% |
| Jun 30, 2022 | 256.09% |
| Mar 31, 2022 | -69.23% |
| Dec 31, 2021 | 72.46% |
| Sep 30, 2021 | 19.26% |
| Jun 30, 2021 | 21.55% |
| Mar 31, 2021 | -57.65% |
| Dec 31, 2020 | -24.32% |
| Sep 30, 2020 | -50.31% |
| Jun 30, 2020 | -33.55% |
| Mar 31, 2020 | -49.66% |
| Dec 31, 2019 | -30.42% |
| Sep 30, 2019 | -32.51% |
| Jun 30, 2019 | -32.99% |
| Mar 31, 2019 | 164.36% |
| Sep 30, 2018 | -10.75% |
| Jun 30, 2018 | 52.52% |
| Mar 31, 2018 | 111.41% |
| Sep 30, 2017 | 27.87% |
| Jun 30, 2017 | -19.63% |
| Mar 31, 2017 | -44.72% |
| Sep 30, 2016 | -39.17% |
| Jun 30, 2016 | -26.99% |
| Mar 31, 2016 | 5.23% |
| Sep 30, 2015 | 52.02% |
| Jun 30, 2015 | 37.81% |
| Mar 31, 2015 | 43.28% |
| Sep 30, 2014 | 35.74% |
| Jun 30, 2014 | 102.01% |
| Mar 31, 2014 | 98.87% |
| Sep 30, 2013 | 26.08% |
| Jun 30, 2013 | 26.24% |